Literature DB >> 26242359

[Non-opioid pain medication in the elderly].

H Burkhardt1, M Wehling.   

Abstract

Non-opioid analgesics are frequently used to control chronic pain in elderly patients; however some of these drugs show high rates of adverse drug reactions. Among these are significant clinical problems which impede an effective and safe pain control. This review provides recent data concerning non-steroidal anti-inflammatory drugs (NSAID), acetaminophen, metamizol and flupirtin. Due to their risk profile NSAIDs are less appropriate due to high incidence rates and drug-related risk patterns. Acetaminophen, metamizol and flupirtin may be recommended instead; however a shortcoming of acetaminophen in comparison to NSAIDs is its weaker action to control pain. Metamizol is still banned in some countries due to rare but potentially severe hematological side effects and flupirtin frequently causes unfavorable sedation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26242359     DOI: 10.1007/s00482-015-0032-2

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  38 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

2.  Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland; Richard Logan
Journal:  BMJ       Date:  2005-12-03

3.  Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.

Authors:  J D Bradley; K D Brandt; B P Katz; L A Kalasinski; S I Ryan
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

Review 4.  Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense.

Authors:  John L Wallace; Pallavi R Devchand
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

Review 5.  Mitigating the cardiovascular and renal effects of NSAIDs.

Authors:  Rodolfo V Curiel; James D Katz
Journal:  Pain Med       Date:  2013-11-20       Impact factor: 3.750

6.  Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells.

Authors:  J F Schmedtje; Y S Ji; W L Liu; R N DuBois; M S Runge
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

7.  Assessing a conceptual model of over-the-counter medication misuse, adverse drug events and health-related quality of life in an elderly population.

Authors:  Shivani K Mhatre; Sujit S Sansgiry
Journal:  Geriatr Gerontol Int       Date:  2015-01-22       Impact factor: 2.730

Review 8.  Hospital-acquired acute kidney injury in the elderly.

Authors:  Alexandra Chronopoulos; Dinna N Cruz; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2010-02-02       Impact factor: 28.314

9.  The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial.

Authors:  Heleen M den Hertog; H Bart van der Worp; H Maarten A van Gemert; Ale Algra; L Jaap Kappelle; Jan van Gijn; Peter J Koudstaal; Diederik W J Dippel
Journal:  Lancet Neurol       Date:  2009-03-16       Impact factor: 44.182

Review 10.  Challenges of managing chronic pain in the elderly.

Authors:  Gary E Ruoff
Journal:  Semin Arthritis Rheum       Date:  2002-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.